Ironwood Pharmaceuticals (IRWD) Shares Outstanding (Diluted Average) (2009 - 2025)

Ironwood Pharmaceuticals has disclosed Shares Outstanding (Diluted Average) across 10 years of filings, most recently posting $161.0 million for Q1 2025.

• Shares Outstanding (Diluted Average) for Q1 2025 came in at $161.0 million, up 2.08% year-over-year; the trailing twelve-month figure through Mar 2025 was $161.0 million (up 2.08% YoY), and the FY2020 annual result was $160.7 million, up 2.97% from the prior year.
• Shares Outstanding (Diluted Average) came in at $161.0 million for Q1 2025 at Ironwood Pharmaceuticals, up from $159.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $161.0 million in Q1 2025 to a low of $154.9 million in Q2 2023.
• The 3-year median for Shares Outstanding (Diluted Average) is $158.4 million (2024), against an average of $158.2 million.
• Across the five-year window, Shares Outstanding (Diluted Average) climbed 2.65% in 2024 and increased 2.08% in 2025, its largest moves.
• Ironwood Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $154.9 million in 2023, then grew by 2.65% to $159.0 million in 2024, then grew by 1.23% to $161.0 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $161.0 million (Q1 2025), $159.0 million (Q2 2024), and $157.7 million (Q1 2024), per Business Quant data.